Mount Vernon Associates’s Affirm AFRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Sell
42,575
-900
-2% -$58.8K 2.26% 13
2026
Q1
$1.99M Buy
43,475
+550
+1% +$31.8K 1.41% 23
2025
Q4
$3.19M Buy
42,925
+200
+0.5% +$14.4K 2.15% 14
2025
Q3
$3.12M Sell
42,725
-800
-2% -$60.9K 2.18% 14
2025
Q2
$3.01M Buy
43,525
+29,975
+221% +$1.55M 2.17% 13
2025
Q1
$612K Buy
13,550
+1,950
+17% +$116K 0.5% 36
2024
Q4
$706K Buy
11,600
+3,600
+45% +$200K 0.55% 36
2024
Q3
$327K Buy
+8,000
New +$265K 0.26% 46

Other funds holding AFRM

Mount Vernon Associates's AFRM Position: Q2 2026 in Review

Mount Vernon Associates reduced its Affirm (AFRM) stake by 2.1% in Q2 2026, selling an estimated $58.8K and leaving 42,575 shares worth $3.47M. The position accounts for 2.26% of the portfolio, ranked #13.

Mount Vernon Associates first reported a position in AFRM in Q3 2024 and has held it in 8 quarters since. 206 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Mount Vernon Associates held 42,575 shares of Affirm worth $3.47M as of Q2 2026.
  • Mount Vernon Associates sold 900 Affirm shares in Q2 2026, an estimated $58.8K.
  • Affirm made up 2.26% of Mount Vernon Associates's portfolio in Q2 2026, its #13 holding.
  • Mount Vernon Associates first reported a position in Affirm in Q3 2024 and has held it in 8 quarters since.
  • 206 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Mount Vernon Associates's 13F filing for Q2 2026, filed 24 Jul 2026.